🕵️ HCA Healthcare, Inc. ($HCA)
SEC insider & ownership activity, last 12 months · CIK 860730 · every row links its SEC filing
Over the last 12 months insiders sold $32.7M with no open-market buying against it. Samuel N. Hazen sold $21.5M (Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $32.7M (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Samuel N. Hazen | 0 | – | 7 | $21.5M | Feb 3, 2026 |
| Jennifer L. Berres | 0 | – | 2 | $4.1M | Feb 11, 2026 |
| Michael R McAlevey | 0 | – | 2 | $2.7M | Feb 18, 2026 |
| Michael S Cuffe | 0 | – | 2 | $2.4M | Feb 3, 2026 |
| Christopher F. Wyatt | 0 | – | 1 | $2.0M | Feb 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Thomas F. Frist, JR. | 31.6% | 13D | Feb 6, 2026 | filing ↗ | |
| William R. Frist | 31.5% | 13D | Feb 6, 2026 | filing ↗ | |
| Patricia F. Elcan | 31.4% | 13D | Feb 6, 2026 | filing ↗ | |
| Thomas F. Frist III | 31.3% | 13D | Feb 6, 2026 | filing ↗ | |
| Frisco Holding II | 17.4% | 13D | Feb 6, 2026 | filing ↗ | |
| Hercules Holding II | 15.5% | 13D | Feb 6, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Michael R McAlevey | $903K | Feb 18, 2026 | filing ↗ |
| Jennifer L. Berres | $4.1M | Feb 11, 2026 | filing ↗ |
| Michael S Cuffe | $747K | Feb 3, 2026 | filing ↗ |
| Samuel N. Hazen | $21.5M | Feb 3, 2026 | filing ↗ |
| Michael R McAlevey | $1.8M | Nov 5, 2025 | filing ↗ |
| Michael S. Cuffe | $1.6M | Sep 8, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 24, 2026 | filing ↗ |
| Other events (8.01) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Earnings (2.02) | Jul 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Earnings (2.02) | Apr 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 24, 2026 | filing ↗ |
| Other events (8.01) | Apr 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 20, 2026 | filing ↗ |
| Earnings (2.02) | Jan 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 27, 2026 | filing ↗ |
| Other events (8.01) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Material agreement (1.01) | Oct 27, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 27, 2025 | filing ↗ |
| Other events (8.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |
| Other events (8.01) | Oct 27, 2025 | filing ↗ |